吉林敖东：淬炼“一瓶良药” 做精“一棵人参”

Core Viewpoint - Jilin Aodong Pharmaceutical Group Co., Ltd. has developed a dual-driven path of "old medicine new making" and "one ginseng drives regional prosperity" over 42 years, focusing on innovation while inheriting traditional practices [1] Product Positioning - The company emphasizes product standards as a passport to high-end markets, striving to enhance product quality and brand positioning [2] Product Development - The "Anshen Bnona Liquid," a compound traditional Chinese medicine, has captured an 80% market share since its inception in 1983, transitioning from local to national standards [3] - The company has expanded its ginseng product line, with 44 medicinal products and over 100 functional foods, projecting a revenue of over 200 million yuan from ginseng products in 2024 [3] Source Foundation - Jilin Aodong adheres to the principle that quality raw materials ensure quality products, with significant investments in GAP-certified bases for deer and local medicinal materials [4] - The company has established over 6,000 acres of medicinal material bases and has received multiple quality certifications for its ginseng and deer products [4] Technological Empowerment - The introduction of an intelligent extraction control system in 2003 has automated the production of Anshen Bnona Liquid, ensuring product safety and consistency [5] - The same technological advancements are being applied to the ginseng sector, enhancing production efficiency and quality assurance [5] Brand Development - The company has successfully leveraged national advertising and sports sponsorships to enhance brand recognition, with plans to expand its ginseng products into international markets [6][7] Research and Development - Continuous R&D efforts have demonstrated the efficacy of Anshen Bnona Liquid in treating neurodegenerative conditions, with recent studies highlighting the potential of deer antler in Alzheimer's treatment [8][9] - The company is also exploring new applications for ginseng saponins in treating various health conditions, aiming to enter the billion-yuan market for brain health [9] Policy Environment - Jilin Aodong benefits from favorable policies that support the development of traditional Chinese medicine and the enhancement of its deer breeding practices, ensuring long-term growth and competitive advantage [10][12]